TrialGynecologic oncology2025

Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263).

Dana M Chase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.